A selective estrogen receptor-β agonist causes lesion regression in an experimentally induced model of endometriosis
Authors:
- Heather A. HarrisHHHeather A. Harris
- Kaylon L. Bruner-TranKBKaylon L. Bruner-Tran
- Xiaochun ZhangXZXiaochun Zhang
- Kevin G. OsteenKOKevin G. Osteen
- C. Richard LyttleCLC. Richard Lyttle
Open Access
- 1 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 20 (4) , 936-941
Abstract
BACKGROUND: Endometriosis is a common gynaecological problem of uncertain aetiology. It affects primarily young, reproductive-aged women and can result in chronic pelvic pain and infertility. Current approved therapies have significant side-effects and hysterectomy is employed as a final solution. ERB-041 is a selective estrogen receptor-β (ERβ) agonist that has anti-inflammatory activity in preclinical models of arthritis and inflammatory bowel disease, but is inactive in many preclinical models of classic estrogen activity. Because endometriosis is now thought to be, at least in part, an inflammatory disease, we evaluated ERB-041's activity in an experimentally induced model of endometriosis. METHODS: Athymic nude mice (ovariectomized or intact) were implanted with tissue fragments of normal human endometrium. After establishment of lesions for 11–14 days, mice were treated with ERB-041 for 15–17 days. Upon euthanasia, the number of lesions, their size and location were noted. Five lesions were recovered for RNA analysis. RESULTS: Across six studies, ERB-041 caused complete lesion regression in 40–75% of the mice studied. The compound appeared to be equally effective in gonad-intact as in ovariectomized mice, and analysed recovered lesions expressed ERα but not ERβ mRNA. CONCLUSIONS: ERB-041 and possibly other ERβ selective agonists may be a useful new approach to treating endometriosis.Keywords
This publication has 27 references indexed in Scilit:
- Design and Synthesis of Aryl Diphenolic Azoles as Potent and Selective Estrogen Receptor-β LigandsJournal of Medicinal Chemistry, 2004
- Matrix Metalloproteinases and EndometriosisSeminars in Reproductive Medicine, 2003
- Pathogenesis of EndometriosisGynecologic and Obstetric Investigation, 2002
- Natural Killer Cells Express Estrogen Receptor-α and Estrogen Receptor-β and Can Respond to Estrogen Via a Non-Estrogen Receptor-α-Mediated PathwayCellular Immunology, 2001
- Immunolocalisation of oestrogen receptor beta in human tissuesJournal of Molecular Endocrinology, 2000
- Progesterone and transforming growth factor-β coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosisSteroids, 1999
- Oestrogen receptor alpha and mRNA expression in human endometrium throughout the menstrual cycleMolecular Human Reproduction, 1999
- Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice.Journal of Clinical Investigation, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986